186 related articles for article (PubMed ID: 29066385)
1. Nebulized coenzyme Q
Rossi I; Sonvico F; McConville JT; Rossi F; Fröhlich E; Zellnitz S; Rossi A; Del Favero E; Bettini R; Buttini F
Eur J Pharm Sci; 2018 Feb; 113():159-170. PubMed ID: 29066385
[TBL] [Abstract][Full Text] [Related]
2. TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10.
Shao Y; Yang L; Han HK
Eur J Pharm Biopharm; 2015 Jan; 89():339-46. PubMed ID: 25542680
[TBL] [Abstract][Full Text] [Related]
3. Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity.
Ishak RA; Osman R
Int J Pharm; 2015 May; 485(1-2):249-60. PubMed ID: 25772421
[TBL] [Abstract][Full Text] [Related]
4. High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation.
Masotta NE; Martinefski MR; Lucangioli S; Rojas AM; Tripodi VP
Int J Pharm; 2019 Feb; 556():9-20. PubMed ID: 30529659
[TBL] [Abstract][Full Text] [Related]
5. Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers.
Beck-Broichsitter M; Kleimann P; Schmehl T; Betz T; Bakowsky U; Kissel T; Seeger W
Eur J Pharm Biopharm; 2012 Oct; 82(2):272-80. PubMed ID: 22820646
[TBL] [Abstract][Full Text] [Related]
6. Efficiency of emulsifier-free emulsions and emulsions containing rapeseed lecithin as delivery systems for vectorization and release of coenzyme Q10: physico-chemical properties and in vitro evaluation.
Kaci M; Arab-Tehrany E; Dostert G; Desjardins I; Velot E; Desobry S
Colloids Surf B Biointerfaces; 2016 Nov; 147():142-150. PubMed ID: 27497933
[TBL] [Abstract][Full Text] [Related]
7. Development of aqueous dispersions of Coenzyme Q
Carvalho TC; McCook JP; Narain NR; McConville JT
Int J Pharm; 2016 Dec; 514(2):407-419. PubMed ID: 27732894
[TBL] [Abstract][Full Text] [Related]
8. Optimization of nutraceutical coenzyme Q10 nanoemulsion with improved skin permeability and anti-wrinkle efficiency.
El-Leithy ES; Makky AM; Khattab AM; Hussein DG
Drug Dev Ind Pharm; 2018 Feb; 44(2):316-328. PubMed ID: 29096550
[TBL] [Abstract][Full Text] [Related]
9. Boosting the aerodynamic properties of vibrating-mesh nebulized polymeric nanosuspensions.
Beck-Broichsitter M; Knuedeler MC; Oesterheld N; Seeger W; Schmehl T
Int J Pharm; 2014 Jan; 459(1-2):23-9. PubMed ID: 24286921
[TBL] [Abstract][Full Text] [Related]
10. Systematic aging of degradable nanosuspension ameliorates vibrating-mesh nebulizer performance.
Dalla-Bona AC; Schmehl T; Gessler T; Seeger W; Beck-Broichsitter M
Drug Dev Ind Pharm; 2015; 41(10):1704-9. PubMed ID: 25519975
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability of coenzyme Q
Ehrenhaus Masotta N; Höcht C; Contin M; Lucangioli S; Rojas AM; Tripodi VP
Int J Pharm; 2020 May; 582():119315. PubMed ID: 32283195
[TBL] [Abstract][Full Text] [Related]
12. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
[TBL] [Abstract][Full Text] [Related]
13. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
[TBL] [Abstract][Full Text] [Related]
14. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
[TBL] [Abstract][Full Text] [Related]
15. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
Nasr M; Najlah M; D'Emanuele A; Elhissi A
Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
[TBL] [Abstract][Full Text] [Related]
16. Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy?
Ankola DD; Viswanad B; Bhardwaj V; Ramarao P; Kumar MN
Eur J Pharm Biopharm; 2007 Sep; 67(2):361-9. PubMed ID: 17452099
[TBL] [Abstract][Full Text] [Related]
17. Controlling the droplet size of formulations nebulized by vibrating-membrane technology.
Beck-Broichsitter M; Knuedeler MC; Seeger W; Schmehl T
Eur J Pharm Biopharm; 2014 Aug; 87(3):524-9. PubMed ID: 24657823
[TBL] [Abstract][Full Text] [Related]
18. Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harboring different surface characteristics.
Lehofer B; Bloder F; Jain PP; Marsh LM; Leitinger G; Olschewski H; Leber R; Olschewski A; Prassl R
Eur J Pharm Biopharm; 2014 Nov; 88(3):1076-85. PubMed ID: 25460154
[TBL] [Abstract][Full Text] [Related]
19. Porous mannitol carrier for pulmonary delivery of cyclosporine A nanoparticles.
Leung SS; Wong J; Guerra HV; Samnick K; Prud'homme RK; Chan HK
AAPS J; 2017 Mar; 19(2):578-586. PubMed ID: 28070713
[TBL] [Abstract][Full Text] [Related]
20. Kolliphor® HS 15 Micelles for the Delivery of Coenzyme Q10: Preparation, Characterization, and Stability.
Liu L; Mao K; Wang W; Pan H; Wang F; Yang M; Liu H
AAPS PharmSciTech; 2016 Jun; 17(3):757-66. PubMed ID: 26340950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
